Influenza vaccine (inactivated)
واکسن آنفلوانزا (غیرفعال)
🦠 Antiinfectives For Systemic UseInactivated vaccine
Market / country: 🇺🇸 USA
Fluzone (US)
🧮 Dose calculator
Immunisation (vaccination) · Regimen source: FDA Fluzone · 2.1, Table 1
- • 6 months–8 y not previously vaccinated: 2 doses at least 4 weeks apart. 6–35 months: each dose 0.25 or 0.5 mL. ≥9 y: one 0.5 mL dose. FDA Fluzone · 2.1, Table 1
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Severe allergic reaction to a component (including egg protein) or a previous dose of any influenza vaccine. FDA Fluzone · 4
Formulations
- 0.5 mL prefilled syringe / multidose vial — injection 🇺🇸 USA FDA Fluzone · 3
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Fluzone · 8.1
“Risk Summary All pregnancies have a risk of birth defect, loss, or other adverse outcomes.”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Fluzone · 8.2
“It is not known if Fluzone is excreted in human milk.”
- 👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Fluzone · 8.4
“Safety and effectiveness of Fluzone in children below the age of 6 months have not been established.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Fluzone · 8.5
“Safety and immunogenicity of Fluzone were evaluated in adults 65 years of age and older.”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)BLA103914
- DailyMed (FDA label)FDA Fluzone
- MedlinePlus (NIH)❌ None
- WHO ATC/DDDJ07BB02
- Darooyab (Iran)Influenza-Vaccines
🇮🇷 Registered in Iran Darooyab · G-3474/Influenza-Vaccines
Dosage forms with Iranian generic codes, per Darooyab.
- 14786 · VACCINE-INFLUENZA A 15MCG 0.5ML VIAL · ویال واکسن–آنفلوانزا A ۱۵ میکروگرم ۰٫۵ میلیلیتر
- 14785 · VACCINE-INFLUENZA A 3.8MCG 0.5ML VIAL · ویال واکسن–آنفلوانزا A ۳٫۸ میکروگرم ۰٫۵ میلیلیتر
- 00667 · VACCINE-INFLUENZA VIRUS KILLED SYRINGE · سرنگ واکسن–آنفلوانزا ویروس کیللد
- 52695 · INFLUENZA VACCINE, INACTIVATED, TETRAVALENT INJECTION PARENTERAL 1 {dose} · فرآورده تزریقی واکسن آنفلوانزا غیرفعالشده تتراوالنت ۱ { دوز }
- 53020 · INFLUENZA VACCINE, RECOMBINANT, TETRAVALENT INJECTION PARENTERAL 1 {dose} 0.5 mL · فرآورده تزریقی واکسن آنفلوانزا نوترکیب تتراوالنت ۱ { دوز } ۰٫۵ میلیلیتر
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Fluzone · 3FDA Fluzone · 2.1, Table 1FDA Fluzone · 4FDA Fluzone · 8.1FDA Fluzone · 8.2FDA Fluzone · 8.4FDA Fluzone · 8.5FDA Fluzone · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-3474/Influenza-Vaccines
- Clinical review⚠ Unverified